Skip to main content

Incannex Healthcare Inc. (IXHL) Stock

Incannex Healthcare Inc. Stock Details, Movements and Public Alerts

Stock Details

Incannex Healthcare Inc. (IXHL), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in Australia and primarily trades on the NCM.Currently, the stock is trading at $3.65. Over the past 52 weeks, it has ranged between $2.49 and $27.69. This places the current price at 13.2% of its 52-week high and 46.6% above its 52-week low. Recent trading volume was recorded at 76,882. The 14-day Relative Strength Index (RSI) stands at 69.51, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $3.34 by 9.28%. Similarly, it is below its 200-day moving average of $6.28 by 41.88%. The MACD histogram is 0.07, indicating bullish momentum (MACD Line: 0.05, Signal Line: -0.02). There are currently 2 active alerts set for IXHL by users.

52-Week Range

$27.69 - $2.49

-86.82% from high · +46.59% from low

Avg Daily Volume

90,779

20-day average

100-day avg: 287,347

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-2.13

Price to Book

0.66

EV/EBITDA

1.30

EPS (TTM)

-$16.62

Beta

2.81

More volatile than market

Q:How is IXHL valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is IXHL's risk profile compared to the market?
With a beta of 2.81, Incannex Healthcare Inc. is significantly more volatile than the market. For every 10% market move, this stock tends to move 28% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 0.66 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-24,695,000

Return on Equity

-117.17%

Return on Assets

-32.19%

Q:How profitable and efficient is IXHL's business model?
Profitability metrics are not available for this stock.
Q:What are IXHL's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$43.3M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

11.96M

Book Value/Share

$5.50

Asset Type

EQUITY

Q:What is IXHL's market capitalization and position?
Incannex Healthcare Inc. has a market capitalization of $43.3M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 11.96M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Drug Manufacturers - Specialty & Generic industry, it competes with other firms in this sector.
Q:How does IXHL's price compare to its book value?
Incannex Healthcare Inc.'s book value per share is $5.50, while the current stock price is $3.65, resulting in a price-to-book (P/B) ratio of 0.66. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$18.17

397.77% upside potential

Analyst Recommendations

No analyst ratings available

Q:How reliable are analyst predictions for IXHL?
0 analysts cover IXHL with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $18.17 implies 397.8% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on IXHL?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 21, 2026, 02:12 AM

Technical Indicators

RSI (14-day)

69.51

Neutral

50-Day Moving Average

$3.34

9.28% above MA-50

200-Day Moving Average

$6.28

-41.88% below MA-200

MACD Line

0.05

MACD Signal

-0.02

MACD Histogram

0.07

Bullish

Q:What does IXHL's RSI value tell investors?
The RSI (Relative Strength Index) for IXHL is currently 69.51, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret IXHL's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.05 above the signal line at -0.02, with histogram at 0.07. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($3.34) is below the 200-day MA ($6.28), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Aug 21, 2026, 01:03 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
10%
Created
Jul 27, 2026, 04:25 PM
Alert Condition
Earnings Announcement
Threshold
3 days
Created
Feb 2, 2026, 04:53 PM

Stay Ahead of the Market with Incannex Healthcare Inc. Alerts

Set up price alerts for Incannex Healthcare Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.